Institutional Ownership Crinetics Pharmaceuticals, Inc. (CRNX)
This table provides information about the institutional ownership of Crinetics Pharmaceuticals, Inc. (CRNX). We have compiled data on the 242 institutions that hold shares in the stock, with a total of 79.6 Million shares, which have been reported (via 13F filing form) to have a value of $4.57 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Gw&K Investment Management, LLC
Boston, MA |
Nov 07, 2024 Q3 2024 |
732,892
shares
|
$42.1 Million
0.32% of portfolio
|
Q3 2024
Added 94.06%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
730,516
shares
|
$41.9 Million
0.01% of portfolio
|
Q3 2024
Added 20.54%
|
|
|
Perceptive Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
724,698
shares
|
$41.6 Million
0.97% of portfolio
|
Q3 2024
Reduced 50.91%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
665,599
shares
|
$38.2 Million
0.0% of portfolio
|
Q3 2024
Reduced 20.63%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
655,418
shares
|
$37.6 Million
0.01% of portfolio
|
Q3 2024
Added 9.78%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Nov 14, 2024 Q3 2024 |
616,837
shares
|
$35.4 Million
0.06% of portfolio
|
Q3 2024
Added 0.1%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
Nov 12, 2024 Q3 2024 |
525,845
shares
|
$30.2 Million
4.19% of portfolio
|
Q3 2024
Reduced 5.62%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
514,194
shares
|
$29.5 Million
0.01% of portfolio
|
Q3 2024
Added 11.11%
|
|
|
Bnp Paribas Asset Management Holding S.A.
|
Nov 08, 2024 Q3 2024 |
491,381
shares
|
$28.2 Million
0.06% of portfolio
|
Q3 2024
Reduced 10.04%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
490,725
shares
|
$28.2 Million
0.18% of portfolio
|
Q3 2024
Reduced 24.91%
|
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
Nov 12, 2024 Q3 2024 |
482,099
shares
|
$27.7 Million
0.01% of portfolio
|
Q3 2024
Added 8.42%
|
|
|
Fiera Capital Corp
Montreal, A8 |
Nov 01, 2024 Q3 2024 |
466,075
shares
|
$26.7 Million
0.08% of portfolio
|
Q3 2024
Reduced 2.98%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Nov 14, 2024 Q3 2024 |
426,913
shares
|
$24.5 Million
3.81% of portfolio
|
Q3 2024
Reduced 27.5%
|
|
|
Affinity Asset Advisors, LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
400,000
shares
|
$23 Million
3.53% of portfolio
|
Q3 2024
Reduced 22.33%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 07, 2024 Q3 2024 |
392,196
shares
|
$22.5 Million
0.0% of portfolio
|
Q3 2024
Reduced 28.27%
|
|
|
American Century Companies Inc
Kansas City, MO |
Nov 12, 2024 Q3 2024 |
386,886
shares
|
$22.2 Million
0.01% of portfolio
|
Q3 2024
Added 3361.14%
|
|
|
Voya Investment Management LLC
Atlanta, GA |
Nov 14, 2024 Q3 2024 |
377,589
shares
|
$21.7 Million
0.02% of portfolio
|
Q3 2024
Added 64.23%
|
|
|
First Turn Management, LLC
Del Mar, CA |
Nov 07, 2024 Q3 2024 |
353,376
shares
|
$20.3 Million
2.86% of portfolio
|
Q3 2024
Reduced 4.31%
|
|
|
Victory Capital Management Inc
|
Nov 05, 2024 Q3 2024 |
343,344
shares
|
$19.7 Million
0.02% of portfolio
|
Q3 2024
Added 51.46%
|
|
|
Stanley Druckenmiller
Duquesne Family Office LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
309,000
shares
|
$17.7 Million
0.53% of portfolio
|
Q1 2024
New holding
|
|
|
Integral Health Asset Management, LLC
|
Nov 14, 2024 Q3 2024 |
300,000
shares
|
$17.2 Million
1.8% of portfolio
|
Q3 2024
Reduced 25.0%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
289,400
shares
|
$16.6 Million
0.5% of portfolio
|
Q1 2024
New holding
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
287,794
shares
|
$16.5 Million
0.02% of portfolio
|
Q3 2024
Reduced 26.38%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
285,956
shares
|
$16.4 Million
0.0% of portfolio
|
Q3 2024
Added 0.31%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
278,073
shares
|
$16 Million
0.0% of portfolio
|
Q3 2024
Reduced 8.88%
|